Evr has been shown to promote the apoptosis of GEM-resistant (GEMres) pancreatic cancer cells by activating caspase-3 and caspase-7 through PI3K/AKT/mTOR signaling (Peng and Dou 2017). The gene discussed is AKT1; the disease is pancreatic neoplasm.